Evidence map›Paper›PMID 38088370›Full record

ArticleClinical and translational gastroenterology2024

Systematic Evaluation of Clinical, Nutritional, and Fecal Microbial Factors for Their Association With Colorectal Polyps.

David Schult, H Carlo Maurer, Marina Frolova, Marc Ringelhan, Ulrich Mayr, Jörg Ulrich, Markus Heilmaier, Sebastian Rasch, Tobias Lahmer, Sandra Reitmeier and 13 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Clinical and translational gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 1 country.

David SchultDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
H Carlo MaurerDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Marina FrolovaDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Marc RingelhanDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Ulrich MayrDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Jörg UlrichDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Markus HeilmaierDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Sebastian RaschDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Tobias LahmerDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Sandra ReitmeierZIEL-Institute for Food & Health, Technische Universität München, Freising, Germany.
Chiara HennigDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Christina GassnerDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Niklas ThurDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Theresa WillDepartment of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Klaus-Peter JanssenDepartment of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Katja SteigerInstitute of Pathology, Technische Universität München, Munich, Germany.
Moritz JesinghausInstitute of Pathology, Technische Universität München, Munich, Germany.
Klaus NeuhausZIEL-Institute for Food & Health, Technische Universität München, Freising, Germany.
Michael QuanteDepartment of Internal Medicine II, Universitätsklinikum Freiburg, Universität Freiburg, Freiburg, Germany.
Dirk HallerZIEL-Institute for Food & Health, Technische Universität München, Freising, Germany.
Mohamed AbdelhafezDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Roland M SchmidDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Moritz MiddelhoffDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.ORCID 0000-0001-8425-3985
TUM Klinikum · DELeibniz-Institute for Food Systems Biology at the Technical University of Munich · DEPhilipps University of Marburg · DETechnical University of Munich · DEUniversity Medical Center Freiburg · DE

Funding

Deutsche Forschungsgemeinschaft 395357507
6 · The paper itself

Abstract

introductionThe identification of risk factors for precursor lesions of colorectal cancer (CRC) holds great promise in the context of prevention. With this study, we aimed to identify patient characteristics associated with colorectal polyps (CPs) and polyp features of potential malignant progression. Furthermore, a potential association with gut microbiota in this context was investigated.

methodsIn this single-center study, a total of 162 patients with CPs and 91 control patients were included. Multiple variables including information on lifestyle, diet, serum parameters, and gut microbiota, analyzed by 16S-rRNA gene amplicon sequencing and functional imputations (Picrust2), were related to different aspects of CPs.

resultsWe observed that elevated serum alkaline phosphatase (AP) levels were significantly associated with the presence of high-grade dysplastic polyps. This association was further seen for patients with CRC. Thereby, AP correlated with other parameters of liver function. We did not observe significant changes in the gut microbiota between patients with CP and their respective controls. However, a trend toward a lower alpha-diversity was seen in patients with CRC. Interestingly, AP was identified as a possible clinical effect modifier of stool sample beta diversity. DISCUSSION: We show for the first time an increased AP in premalignant CP. Furthermore, AP showed a significant influence on the microbial composition of the intestine. Relatively elevated liver enzymes, especially AP, may contribute to the detection of precancerous dysplastic or neoplastic changes in colorectal lesions. The association between elevated AP, premalignant CP, and the microbiome merits further study.

Indexed as

Colonic PolypsColorectal NeoplasmsGastrointestinal MicrobiomeBacteriaFecesHumansHyperplasia

Identifiers

PMID38088370
PMCPMC10887443
OpenAlexW4389674381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.